Rigel Pharmaceuticals, Inc. (RIGL)
39.65
-6.06
(-13.26%)
USD |
NASDAQ |
Nov 06, 16:00
39.60
-0.05
(-0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Long Term Debt (Quarterly) : 7.236M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.236M |
| June 30, 2026 | 39.29M |
| March 31, 2026 | 45.08M |
| December 31, 2025 | 52.69M |
| September 30, 2025 | 60.29M |
| June 30, 2025 | 60.53M |
| March 31, 2025 | 60.61M |
| December 31, 2024 | 59.68M |
| September 30, 2024 | 59.76M |
| June 30, 2024 | 59.69M |
| March 31, 2024 | 59.79M |
| December 31, 2023 | 59.89M |
| September 30, 2023 | 60.12M |
| June 30, 2023 | 60.20M |
| March 31, 2023 | 60.29M |
| December 31, 2022 | 40.42M |
| September 30, 2022 | 45.17M |
| June 30, 2022 | 35.54M |
| March 31, 2022 | 35.45M |
| December 31, 2021 | 20.67M |
| September 30, 2021 | 28.70M |
| June 30, 2021 | 31.21M |
| March 31, 2021 | 28.14M |
| December 31, 2020 | 30.47M |
| September 30, 2020 | 32.76M |
| Date | Value |
|---|---|
| June 30, 2020 | 35.06M |
| March 31, 2020 | 27.13M |
| December 31, 2019 | 29.04M |
| September 30, 2019 | 30.97M |
| June 30, 2019 | 23.09M |
| March 31, 2019 | 24.95M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.251B |
| Inovio Pharmaceuticals, Inc. | 5.103M |
| United Therapeutics Corp. | 0.00 |
| Verastem, Inc. | 127.79M |
| Marker Therapeutics, Inc. | 0.00 |